{"name":"Braintree Laboratories","slug":"braintree-laboratories","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2009-01-01","label":"SUPREP Bowel Prep Kit first approved","drug":"SUPREP Bowel Prep Kit","drugSlug":"suprep-bowel-prep-kit","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"oncology","drugs":[{"name":"FDA approved bowel preparation containing electrolytes","genericName":"FDA approved bowel preparation containing electrolytes","slug":"fda-approved-bowel-preparation-containing-electrolytes","indication":"Other","status":"marketed"},{"name":"HalfLytely with Bisacodyl Tablets Bowel Prep Kit","genericName":"HalfLytely with Bisacodyl Tablets Bowel Prep Kit","slug":"halflytely-with-bisacodyl-tablets-bowel-prep-kit","indication":"Other","status":"marketed"},{"name":"Magnesium bowel preparation","genericName":"Magnesium bowel preparation","slug":"magnesium-bowel-preparation","indication":"Other","status":"phase_3"},{"name":"PEG3350","genericName":"PEG3350","slug":"peg3350","indication":"Other","status":"marketed"},{"name":"SUPREP Bowel Prep Kit","genericName":"SUPREP Bowel Prep Kit","slug":"suprep-bowel-prep-kit","indication":"Other","status":"marketed"},{"name":"Visicol","genericName":"Visicol","slug":"visicol","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"FDA approved bowel preparation containing electrolytes","genericName":"FDA approved bowel preparation containing electrolytes","slug":"fda-approved-bowel-preparation-containing-electrolytes","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"HalfLytely with Bisacodyl Tablets Bowel Prep Kit","genericName":"HalfLytely with Bisacodyl Tablets Bowel Prep Kit","slug":"halflytely-with-bisacodyl-tablets-bowel-prep-kit","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Magnesium bowel preparation","genericName":"Magnesium bowel preparation","slug":"magnesium-bowel-preparation","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"PEG3350","genericName":"PEG3350","slug":"peg3350","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SUPREP Bowel Prep Kit","genericName":"SUPREP Bowel Prep Kit","slug":"suprep-bowel-prep-kit","phase":"marketed","mechanism":"SUPREP works by drawing water into the intestines to flush out the contents, preparing the bowel for colonoscopy.","indications":[],"catalyst":""},{"name":"Visicol","genericName":"Visicol","slug":"visicol","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNVGZQWDVERGplY1Q2dzhWWVNoN1lILWE1Y0ZuemhZQjFxUWhBMXg2bDgxaHMyQWxNN09JTHZSTGE0aF9raG1RZHhSVWE0MWh3TElKV3gxX1dTZzZ1VzU2dmJFRWJjdGpOVUd0eW1VZmNpZV8tT3p2OEI3QXZxSXZibGxZNDZNUTJFYVllQThhbTN2ejVFRExFaXdSUm5DeFZsZmloWlhEWQ?oc=5","date":"2026-02-07","type":"regulatory","source":"lupin.com","summary":"Lupin Receives FDA Approval for Generic Suprep® Bowel Prep Kit - Lupin | Press Release - lupin.com","headline":"Lupin Receives FDA Approval for Generic Suprep® Bowel Prep Kit - Lupin | Press Release","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAxWkp3WElUam1UaXZ0N1BXX2ZWb2xMNTM1YnpfUUdLajVfLXB6MWVsellXUnppTHRhSDE1WVFLTEZWQkxPcTFBRVJydjdlbEoxWEw3SGJoLURtbXNmNmIxaVlHQUdwN0tFSDBlMlpR0gFyQVVfeXFMTmp2LXdEaWlwSnh0WjR5YnFKclI0cTlFc0lRUUJ0cGxqdEFiQmNkeXNWVmczVUVSYVlYSG84M3MyN0s4TWxkMk1jSS14aEhRbE5JVm5HbVJLVWg4eFdGYjZUeTdJZ1BYUHVZMEVfUF9NYnlB?oc=5","date":"2026-01-13","type":"regulatory","source":"koreabiomed.com","summary":"HK inno.N submits NDA for K-CAB to FDA to target US gastrointestinal market - koreabiomed.com","headline":"HK inno.N submits NDA for K-CAB to FDA to target US gastrointestinal market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQOTU2QlhjTTlGVHNzR250S2lJY0t5bG54aGpWNXlXblpkaS1tazVPcGZwNGt4UkNZR1gwT0g4TVk5MWxNdzZGbHl4TEZfdE9iWTlxNTZCbnIzaDAtaFJweWxzT3F0bVh2ZDlLdFluWjZSS0tYVHcyZUxWQk53NUpydTRaSDNPbTRvVElubjNKZHphRmVHZUYxRmpPdlNNNnhlZEZLMHFneE10em0zZ1NtblhFbFkxY28wVkZFVTJCX2Z2TE5CejFfekNzSm5SQXRTZ2RpU0dKV2ZueWdnTjFYWUpaOUhGNFBmNnRwVW1yTmRSV2VtRmVhYlpUSjR6T1B0OGs5a0hpUDVDZ2ZjNzBmcWFNVkl3VGRMcWdaTkJjZjFHVFp2?oc=5","date":"2026-01-12","type":"regulatory","source":"PR Newswire","summary":"Sebela Pharmaceuticals® Announces Submission of New Drug Application to FDA for Tegoprazan for the Treatment of Gastroesophageal Reflux Disease - PR Newswire","headline":"Sebela Pharmaceuticals® Announces Submission of New Drug Application to FDA for Tegoprazan for the Treatment of Gastroes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPcm1HMmdQOHpxSE9EOUtoMi1OeFFvRmxpaTdiRnF6eHRLUnJEWEx3WWNhaUUtSlFpOVVtcmQ1ZHJSZ2dFcktISTdDeW5UVGNJbUR1OWotem9jNmxTZlgtOTFJS3VTeHB6bFotQXBDWHFnZldEejBXX0Vfc2Z5V2dKZndOZDRBTEU2WWxZQ0JB?oc=5","date":"2026-01-12","type":"regulatory","source":"HCPLive","summary":"Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications - HCPLive","headline":"Tegoprazan NDA Seeks FDA Approval for 3 GERD Indications","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPc0ROWTY0R2RqLUhIeUIwM19NQWFkaFVKMUFuR0VCU2JiSEdyaDdieDRqNERGT3lsWjg0OUY5Z3pLX1BCMHNmNFFubUpjODJxTHpkUFJjeEIyZ0hiU3lrNUloaGFMNGlzZ3ZPS1BfT2FBNWwxUWpycHRHdDNXOFRhcXRzdk5sX3NtQ3d2TmlOd2NFRy1renlMZFU3Wk1UZGNzOG5VZEstZ1YxRGh4bzJNUW1ERUNRejNWdTZmVHdRbzlzcjlodGh6SFQ2TWNfcmtUMjlvTGg5UmNfR0haNEtlN1ByOXlEZ1N0eDcxUG1lemY3bXpUalIxLTVvRXdFREhSUkFCZkI5YThXNFNvbTAxTkR3?oc=5","date":"2025-11-17","type":"pipeline","source":"GlobeNewswire","summary":"Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity - GlobeNewswire","headline":"Azurity Pharmaceuticals and Sebela Pharmaceuticals Announce the Sale of Sebela’s Bowel Prep Franchise to Azurity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1uQ2diSmhEMy1UQkJlbGtjLV8yN044aTNXRU9jNXkxQjNwdnN0MDZPdUJId0NreExVbGlVZC0xWk1xZzg2NTJDYko0QjZ0ZTdobE1mMy1iMkRkcHRTdDBHV3RPSi02c210TUcxTEtR0gFyQVVfeXFMTlBFX3NBN25qZXFSeEx4RlNiZXc3ak45Ui11ODFCbFBCOEVZUkVCUnhqZDBNeWU1bDlsek1MZ21JY29SU2V1anlIRmx2VlZKSlVMaE1mTFJoUmZqYkxEOEdCaEhDUVdITGlXV0hMQk9td0h3?oc=5","date":"2025-08-08","type":"regulatory","source":"koreabiomed.com","summary":"HK inno.N’s K-CAB clears US trial hurdle, eyeing FDA filing this year - koreabiomed.com","headline":"HK inno.N’s K-CAB clears US trial hurdle, eyeing FDA filing this year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAJBVV95cUxORU1PZ1VweTN4dmJhLXQyTm9VSldjU3hIRlRkMFc5TkZBTUJxUFVxRWxpOVFPWUNKTEp1VnhLTVNta1U1NXNsUlhSOVROd2R3Z0dDYWxBcjIzNENrNl9kWVFpZWpBM2dfd2Znd2VSeXkybzFQNWFZbEdydDNLTTA5Qkk2SzlzVjZPYXNEOVVnQTlCZlNzWnpSajI1eGFzUm1RVjhNZ0xfc3gzR3JOMUJobTZoSDlPd2pCZUhEekotbFItcDllX3FoY3E5d3NtSE4wSVExWk8wM1k3dldia1BSOTdjbHJiWnM0azdtN2NsTm1kWTBLb3BJMWlNd3EwV05nYWZlQkZia3FHdzBqcGFzOTROeE1lc1dvN3NST1ZtR3hSbkhWV3RFa1UzSUlJa01y?oc=5","date":"2025-08-07","type":"trial","source":"PR Newswire","summary":"Sebela Pharmaceuticals® Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 24-Week Maintenance Phase Results - PR Newswire","headline":"Sebela Pharmaceuticals® Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 2","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPd2tidDEtT1pOd05qWW94ZndJbjJBYTBCR2ZlMVNPZFdOS216cjN2WngxcEhzTTBEZ2lYRGtrcGlqQlFhWlNNMjhTRl9TbE8yQ2I3bHU5enR1eDF2eUJvVktsaGwxUXlIX3UzUThOb0RiZ19lbnY1X1V6YVRpNnoyX1dOUEhCOFplTmJfZW9WUmFJSkRsek00RXA5X20wdE9JVGFuempFdWVaTktzUkpkZDVxc0kteFZRdjNlWGkwNUVNLUpGX3Z0aFlpWnI4S2FhS3NVTzFrTDNKTXlpWTR6RDVqZFB0TGlmUkpmb1dvb2xVd0pZVHh3?oc=5","date":"2025-04-23","type":"trial","source":"PR Newswire","summary":"Sebela Pharmaceuticals® Announces Positive Topline Results from Phase 3 TRIUMpH Program of Tegoprazan in GERD - PR Newswire","headline":"Sebela Pharmaceuticals® Announces Positive Topline Results from Phase 3 TRIUMpH Program of Tegoprazan in GERD","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQRVNVZUtrc2pXLW5admxwSGYyYnpoTmNKWG5TSGJZaUs4OFMxN3BocGJtMjVvVDJBMHp5bzNZai11MXdJZmRzeTNpcF9LTXNDMlJzeVVvQWNYOEF1TlVrcWJNZ3ZQRDZPUUVhWHIya2ljS2FBS0hYVlZNOTNWdzRfOEdlXzdCM01NbVpwLW0zd0NQeUhNOVg3TW9mXzkzUU12UFJYcWdDdXFzYUVMeVc0U0dUQUtQemtxUWRtaFgxVDZLR3NaTGZfcFpOdTd3QzNSZHc?oc=5","date":"2023-06-22","type":"regulatory","source":"BioSpace","summary":"FDA Approves Sebela Pharmaceuticals' SUFLAVE™ A New Colonoscopy Preparation that Tastes Similar to a Sports Drink - BioSpace","headline":"FDA Approves Sebela Pharmaceuticals' SUFLAVE™ A New Colonoscopy Preparation that Tastes Similar to a Sports Drink","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPc2hnbk5TZlIyd3ZzVExNYlR1NlB3N05qdU40MVQyNm5fNWFra2gtanJWS1d2c3VrSTdNQUtiMHo3TlZjU0Q0czdlbmprbXpYaDZ4WTctdXhUSWZleXQ4N1djbXdybVdNLXBGWnBFc0tGY2hwSk9DT0hEOEFTV3BGQmlTN1lfSVN2cWcxeFdKaGRnVXFaeVR5SDV5bjJ6d0ZXTDc5cjhqbXlYNVpzUWJQNV9IeFZma0JzS0w1RXQ2RVJVNVk?oc=5","date":"2022-10-04","type":"regulatory","source":"Fierce Pharma","summary":"Constipation prescription awareness remains low despite known risks of long-term OTC meds: report - Fierce Pharma","headline":"Constipation prescription awareness remains low despite known risks of long-term OTC meds: report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE41bnJsSTFvSXBKRFdzZDlVQktENWE5WjFNSGFLVUxLYTBZd2NLdW9hSEZfd2lDa0dyOWViY1BOVnJSNnBTSDlnVTBsdUxYeXlqc2ZhVW9vQ3FXV21tOThBbHl5X00yZTFaWl9BclppcGtjaWdw?oc=5","date":"2021-12-24","type":"pipeline","source":"KED Global","summary":"HK inno.N’s K-CAB a blockbuster drug with $843 million exports - KED Global","headline":"HK inno.N’s K-CAB a blockbuster drug with $843 million exports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOamV3TG1jSkZfOFk0V09qZndYTGNISkRsT0pYa0EwOEhVdGNYM1ZXWUF3VXBncGJnMG0xVVhvandZcXJEMUtPMDlLTXZLcU1zZ0J1TFpwRFB2anZJbEsyWHJCcVIyOHdtb0dGZzZuUHpLbkE4TlZ4TGdCaWYwM0ZIbi00ZFBkcXpuV0NGMFE2VUVXbENhYlF2LWd1QjE0TlpyRFEwYm1SRGd5OW5uRS14UEZ1ckZTeEE2N0o3Vm9WeXFSbkFVci1Gam5tbjdzaGM?oc=5","date":"2021-01-05","type":"pipeline","source":"BioSpace","summary":"Sebela Pharmaceuticals Announces U.S. Launch of SUTAB® Tablets, An Alternative to Liquid Colonoscopy Preparation - BioSpace","headline":"Sebela Pharmaceuticals Announces U.S. Launch of SUTAB® Tablets, An Alternative to Liquid Colonoscopy Preparation","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"marketed":4,"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}